All News

The rule builds on the FDA’s ongoing effort to encourage complete postmarketing safety data on various biologic and device products.

Both combination product applicants and constituent part applicants are required to comply with postmarketing safety reporting rules.

Most quality indicators for diabetes care monitor risk factors to see if patients are reaching their target levels.

Cempra’s community-acquired bacterial pneumonia antibiotic drug rejected by FDA.

FDA proposal would add 6 bulk drug substances and remove 4 substances that can be used in compounding.

Revisions would add 6 bulk drug substances and remove 4 substances that can be used in compounding.

Researchers from Australia set out to determine health consumers' information needs and concerns related to childhood vaccination.

Celiac disease is a disorder that renders sufferers intolerant to gluten.

Hepatitis A infection rates have decreased in the United States and are the lowest they have been in 40 years.

The FDA has created a new proposed rule that adds 6 bulk drug substances to an existing list of substances that can be used in compounding. It has also proposed the removal of 4 other bulk drug substances from the list.

The most popular articles of the year from the American Journal of Pharmacy Benefits.

Top articles of the year on Specialty Pharmacy Times.

Pharmacists improve care for patients in many settings, especially for diabetes.

A new survey reveals patients are concerned about costs, but largely unaware of health plan benefits.

Association between cancer diagnosis and suicide on a population level suggested.

Reduced reimbursements, Medicare Part D, and the Affordable Care Act have stimulated pharmacies to offer a broader palette of services.

Biosimilar erythropoiesis-stimulating agent epoetin was well-tolerated and efficacious in the treatment of geriatric patients with chemotherapy-induced anemia.

Smaller co-payments for prescription drugs leaves individuals less likely to visit the hospital.

Despite universal recommendations for clinicians to routinely immunize 11-to-12 year olds against human papillomavirus (HPV), Healthy People 2020 reports that only 28% of girls and 7% of boys complete the series.

2016 is coming to a close, so we thought we'd take a look back at some of our top-read contributor columns of the year.

Sage Therapeutics is beginning studies to explore the use of SAGE-217 in patients with Parkinson’s disease and essential tremors.

This year's top drug approvals.

Top oncology articles of 2016 on Specialty Pharmacy Times.

New cancer-spreading protein discovered in groundbreaking study.

Relapsed or refractory leukemia patients who received CC-486 had a 38% overall response rate.

Breast cancer patients with many social ties have significantly lower rates of death and recurrence.

Nivolumab plus ipilimumab deemed tolerable in non-small cell lung cancer patients, with notable improvements in safety.

Vaccine-preventable disease death rates have decreased since 1980.

Billions wasted each year from lack of adherence to prescription medications.

Homeopathy is based on the Principle of Similars which means “likes cure likes."